ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 63 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $13,121,568 | 3.65% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,253,478 | 1.30% |
| RA Capital Management | 14,932,063 | $57,339,122 | 0.90% |
| Parkman Healthcare Partners LLC | 603,497 | $2,317,428 | 0.33% |
| Rock Springs Capital Management LP | 2,300,059 | $8,832,227 | 0.22% |
| Ikarian Capital, LLC | 315,265 | $1,210,617 | 0.11% |
| CATALYST FINANCIAL PARTNERS LLC | 89,699 | $344,444 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 246,895 | $948,077 | 0.09% |
| Laurion Capital Management LP | 1,895,023 | $7,276,888 | 0.06% |
| Intrepid Financial Planning Group LLC | 30,150 | $115,776 | 0.06% |